CLINICAL_TRIALS
trial_result
· 2021-01-14
Clinical Trial Update: Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients [Phase 2]
Summary
Phase 2 study evaluating nilotinib treatment-free remission in chronic myeloid leukemia patients has completed, with results posted January 14, 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-01-14